Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13658
Abstract: Cannabinoids are compounds with pleiotropic properties that act on the cannabinoid receptors, CB1 and CB2, and are divided into endocannabinoids, the endogenous ligands of these receptors, synthetic cannabinoids and phytocannabinoids. The latter are derived from… read more here.
Keywords: neurology; immunomodulation revisited; multiple sclerosis; therapeutic cannabinoids ... See more keywords